(2023)
Effect of high-dose radiation therapy on positive margins after breast-conserving surgery for invasive breast cancer.
BREAST.
71,
10
(2023)
Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy.
WORLD JOURNAL OF CLINICAL CASES.
26,
11
(2023)
The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial.
FRONTIERS IN ONCOLOGY.
13,
(2023)
Robotic versus endoscopic transoral thyroidectomy in papillary thyroid cancer: A comparative analysis of surgical outcomes in 240 consecutive patients.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK.
4,
45
(2022)
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?.
JOURNAL OF CLINICAL MEDICINE.
11,
21
(2022)
Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy.
ONCOLOGY.
100,
10
(2022)
Robot-assisted Nipple-sparing Mastectomy With Immediate Breast Reconstruction An initial Experience of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG).
ANNALS OF SURGERY.
275,
5
(2022)
Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society.
JOURNAL OF BREAST CANCER.
25,
2
(2021)
Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer.
EJSO.
47,
2
(2020)
Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model.
IN VIVO.
34,
6
(2020)
Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer.
IN VIVO.
34,
5
(2020)
Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients.
NUTRIENTS.
12,
9
(2020)
A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model.
ANTICANCER RESEARCH.
40,
5
